The National Pharmaceutical Pricing Authority (NPPA) on July 18, 2024, issued the notification regarding Computation of Retail Price of Clindamycin Moxifloxacin Hydrochloride eq to Moxifloxacin IP 0.5%w/v Eye Drops.
The following has been stated namely: -
• The retail price is computed based on the data from November, 2023
• The retail price is computed of drug composing of Clindamycin Moxifloxacin Hydrochloride eq to Moxifloxacin IP 0.5%w/v Eye Drops for M/s Appasamy Ocular Devices P Ltd (Manufacturer) & M/s Mankind Prime Labs Pvt Ltd (Marketer).
• The Total MAT is 1,94,11,91,864.
[Notification No. 19(4122)/2024/DP/NPPA/DIV.II]
